Arlington Trust CO LLC Neogenomics Inc Transaction History
Arlington Trust CO LLC
- $422 Million
- Q2 2024
A detailed history of Arlington Trust CO LLC transactions in Neogenomics Inc stock. As of the latest transaction made, Arlington Trust CO LLC holds 108 shares of NEO stock, worth $1,488. This represents 0.0% of its overall portfolio holdings.
Number of Shares
108
Previous 108
-0.0%
Holding current value
$1,488
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding NEO
# of Institutions
278Shares Held
127MCall Options Held
581KPut Options Held
107K-
Black Rock Inc. New York, NY19.7MShares$271 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.1MShares$195 Million0.0% of portfolio
-
Brown Advisory Inc8.77MShares$121 Million0.16% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.73MShares$92.7 Million0.06% of portfolio
-
Janus Henderson Group PLC London, X06.62MShares$91.2 Million0.05% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $1.73B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...